Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Qui est le CEO de Takeda Pharmaceutical Company Limited ?
Mr. Christophe Weber est le President de Takeda Pharmaceutical Company Limited, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action Takeda Pharmaceutical Company L ?
Le prix actuel de Takeda Pharmaceutical Company L est de $16.67, il a diminué de 0.29% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Takeda Pharmaceutical Company Limited ?
Takeda Pharmaceutical Company Limited appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Takeda Pharmaceutical Company Limited ?
La capitalisation boursière actuelle de Takeda Pharmaceutical Company Limited est de $52.6B
Est-ce que Takeda Pharmaceutical Company Limited est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 16 analystes ont établi des notations d'analystes pour Takeda Pharmaceutical Company Limited, y compris 3 achat fort, 8 achat, 9 maintien, 0 vente et 3 vente forte